Fate Therapeutics
+$0.70 (+3.13%) Today
-$0.35 (-1.52%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.
About FATE
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.
CEO
J. Scott Wolchko
Employees
449
Headquarters
San Diego, California
Founded
2007
FATE Key Statistics
Market cap
2.23B
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.07M
High today
$23.38
Low today
$21.02
Open price
$22.96
Volume
1.39M
52 Week high
$97.43
52 Week low
$20.49
Analyst ratings
85%
of 20 ratings
Buy
85%
Hold
15%
Sell
0%
FATE Earnings
-$0.76
-$0.51
-$0.25
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, After Hours